{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:15:03Z","timestamp":1790936103003,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.jaad.2007.07.016","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T07:08:24Z","timestamp":1187334504000},"page":"1059-1068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Interleukin-12, interleukin-23, and psoriasis: Current\u00a0prospects"],"prefix":"10.1016","volume":"57","author":[{"given":"Dorothea C.","family":"Torti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.07.016_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1648","article-title":"New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions","volume":"5","author":"Hunter","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1634\/theoncologist.1-1-88","article-title":"Interleukin 12: basic biology and potential applications in cancer treatment","volume":"1","author":"Robertson","year":"1996","journal-title":"Oncologist"},{"key":"10.1016\/j.jaad.2007.07.016_bib3","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.4049\/jimmunol.162.12.7480","article-title":"IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder","volume":"162","author":"Hong","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib4","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2007.07.016_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1523-1747.1998.00347.x","article-title":"Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes","volume":"111","author":"Teunissen","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1523-1747.2001.01441.x","article-title":"Inflammatory skin disease in K14\/p40 transgenic mice: evidence for interleukin-12-like activities of p40","volume":"117","author":"Kopp","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib7","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.4049\/jimmunol.170.11.5438","article-title":"IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14\/p40 transgenic mice: evidence for enhanced cutaneous immunity","volume":"170","author":"Kopp","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib8","first-page":"86","article-title":"A study on the expression of interleukin (IL)-10 and IL-12 P35, P40 mRNA in the psoriatic lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"J Tongji Med Univ"},{"key":"10.1016\/j.jaad.2007.07.016_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.0007-0963.2004.05891.x","article-title":"Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris","volume":"150","author":"Lew","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinbiochem.2005.11.008","article-title":"The role of interleukin-12 in the pathogenesis of psoriasis","volume":"39","author":"Shaker","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jaad.2007.07.016_bib11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1046\/j.1523-1747.1998.00446.x","article-title":"Expression of interleukin-12 is increased in psoriatic skin","volume":"111","author":"Yawalkar","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2007.07.016_bib13","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.176.3.1908","article-title":"In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin","volume":"176","author":"Piskin","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000018222","article-title":"Effects of cyclosporin A on immune activation markers in patients with active psoriasis","volume":"199","author":"Economidou","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.07.016_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09629350310001619753","article-title":"Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity","volume":"12","author":"Jacob","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaad.2007.07.016_bib16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.0906-6705.2004.00246.x","article-title":"Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers\u2013IL-12, IL-18 and IL-23","volume":"13","author":"Piskin","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib17","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1365-2133.2006.07180.x","article-title":"Interleukin 12 production by monocytes from patients with psoriasis and its inhibition by cyclosporin A","volume":"154","author":"Tada","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib18","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4049\/jimmunol.175.4.2721","article-title":"TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques","volume":"175","author":"Gottlieb","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib19","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1073\/pnas.0409569102","article-title":"Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris","volume":"102","author":"Chamian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2007.07.016_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2133.2003.05411.x","article-title":"Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis","volume":"149","author":"Hensen","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1523-1747.1999.00654.x","article-title":"Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis","volume":"113","author":"Reich","year":"1999","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1034\/j.1600-0625.2003.00040.x","article-title":"Association scan of the novel psoriasis susceptibility region on chromosome 19:\u00a0evidence for both susceptible and protective loci","volume":"12","author":"Hensen","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00439-002-0851-y","article-title":"Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility","volume":"112","author":"Speckman","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaad.2007.07.016_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.0022-202X.2004.22427.x","article-title":"Psoriasis is not associated with IL-12p70\/IL-12p40 production and IL12B promoter polymorphism","volume":"122","author":"Litjens","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0923-1811(02)00072-5","article-title":"Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris","volume":"30","author":"Tsunemi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2007.07.016_bib26","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.4049\/jimmunol.167.12.6957","article-title":"A protective and agonistic function of IL-12p40 in mycobacterial infection","volume":"167","author":"Holscher","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.175.2.788","article-title":"IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available","volume":"175","author":"Khader","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib28","first-page":"423","article-title":"The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection","volume":"84","author":"Cooper","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.jaad.2007.07.016_bib29","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.4049\/jimmunol.167.9.5304","article-title":"IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis","volume":"167","author":"Lehmann","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/iai.64.1.189-196.1996","article-title":"Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid","volume":"64","author":"Mastroeni","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2007.07.016_bib31","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/iai.64.4.1437-1440.1996","article-title":"Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin","volume":"64","author":"Kincy-Cain","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2007.07.016_bib32","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/IAI.70.4.1936-1948.2002","article-title":"In\u00a0vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70","volume":"70","author":"Elkins","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2007.07.016_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20050193","article-title":"Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae","volume":"202","author":"Happel","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2007.07.016_bib34","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4049\/jimmunol.168.4.1804","article-title":"Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma","volume":"168","author":"Simmons","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib35","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.4049\/jimmunol.152.4.1883","article-title":"Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice: reversal by IFN-gamma","volume":"152","author":"Tripp","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/mpat.1994.1064","article-title":"Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection","volume":"17","author":"Wagner","year":"1994","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jaad.2007.07.016_bib37","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/iai.65.9.3731-3735.1997","article-title":"Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci","volume":"65","author":"Mancuso","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2007.07.016_bib38","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.4049\/jimmunol.173.3.1887","article-title":"IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12","volume":"173","author":"Lieberman","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib39","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1002\/eji.200424993","article-title":"Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control","volume":"34","author":"Vossenkamper","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib40","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/iai.62.7.2818-2824.1994","article-title":"Production of gamma interferon by natural killer cells from Toxoplasma gondii\u2013infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha","volume":"62","author":"Hunter","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2007.07.016_bib41","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/516482","article-title":"Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis","volume":"175","author":"Murray","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2007.07.016_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N","article-title":"Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani","volume":"28","author":"Engwerda","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib43","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2227::AID-IMMU2227>3.0.CO;2-N","article-title":"The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis","volume":"28","author":"Constantinescu","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib44","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/eji.1830260722","article-title":"Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response","volume":"26","author":"Mattner","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib45","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/1521-4141(200007)30:7<2007::AID-IMMU2007>3.0.CO;2-W","article-title":"Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major\u2013infected mice","volume":"30","author":"Hondowicz","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4049\/jimmunol.165.2.896","article-title":"IL-12 is required to maintain a\u00a0Th1 response during Leishmania major infection","volume":"165","author":"Park","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib47","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1128\/jvi.71.10.7799-7803.1997","article-title":"Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections","volume":"71","author":"Carr","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.jaad.2007.07.016_bib48","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.180.6.2199","article-title":"In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS)","volume":"180","author":"Gazzinelli","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2007.07.016_bib49","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1128\/jvi.69.12.8147-8150.1995","article-title":"The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon","volume":"69","author":"Ozmen","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.jaad.2007.07.016_bib50","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1073\/pnas.92.15.6847","article-title":"Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice","volume":"92","author":"Milich","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2007.07.016_bib51","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.4049\/jimmunol.155.12.5684","article-title":"IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system","volume":"155","author":"Bi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib52","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1128\/JVI.72.6.4825-4831.1998","article-title":"Role of interleukin-12 in primary influenza virus infection","volume":"72","author":"Monteiro","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.jaad.2007.07.016_bib53","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1089\/107999099313082","article-title":"The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40","volume":"19","author":"Carr","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jaad.2007.07.016_bib54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/ajrcmb.17.6.2879","article-title":"IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice","volume":"17","author":"Hoag","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaad.2007.07.016_bib55","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1128\/IAI.66.10.4994-5000.1998","article-title":"Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans","volume":"66","author":"Decken","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2007.07.016_bib56","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0161-5890(02)00017-2","article-title":"Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update","volume":"38","author":"Doffinger","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-006-7830-3","article-title":"Presentation of interleukin-12\/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections","volume":"26","author":"Sanal","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib58","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.20060085","article-title":"X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production","volume":"203","author":"Filipe-Santos","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2007.07.016_bib59","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.0022-202X.2004.23448.x","article-title":"A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis","volume":"123","author":"Kauffman","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.07.016_bib60","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa062382","article-title":"A human interleukin-12\/23 monoclonal antibody for the treatment of psoriasis","volume":"356","author":"Krueger","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.07.016_bib61","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.ibd.0000225337.14356.31","article-title":"A phase 1\/2A trial of STA 5326, an oral interleukin-12\/23 inhibitor, in patients with active moderate to severe Crohn's disease","volume":"12","author":"Burakoff","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2007.07.016_bib62","unstructured":"Gordon K, Tschen E, Korman N, Cather J, Gold M, Hampel F, et\u00a0al. A phase II study of STA-5326, an oral IL-12 and IL-23 inhibitor, in patients with moderate to severe chronic plaque psoriasis. Paper presented at: 4th International Congress The Royal College of Physicians; December 1-3, 2005; London, United Kingdom."},{"issue":"Suppl","key":"10.1016\/j.jaad.2007.07.016_bib63","first-page":"S25","article-title":"How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease","volume":"4","author":"Sandborn","year":"2004","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.jaad.2007.07.016_bib64","unstructured":"ABT-874. Available from: URL:http:\/\/www.cambridgeantibody.com. Accessed May 16, 2006."},{"key":"10.1016\/j.jaad.2007.07.016_bib65","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.4049\/jimmunol.177.7.4917","article-title":"An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12\/IL-23 in psoriasis","volume":"177","author":"Toichi","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib66","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.168.3.1322","article-title":"Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if\u00a0the IL-12 p40 subunit is present","volume":"168","author":"Cooper","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib67","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.153.6.2533","article-title":"Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii","volume":"153","author":"Gazzinelli","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib68","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.165.2.969","article-title":"A natural model of Leishmania major infection reveals a prolonged \u201csilent\u201d phase of parasite amplification in the skin before the onset of lesion formation and immunity","volume":"165","author":"Belkaid","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.07.016_bib69","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.4049\/jimmunol.167.6.3346","article-title":"IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18","volume":"167","author":"Muller","year":"2001","journal-title":"J\u00a0Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207011644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207011644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:08:18Z","timestamp":1759270098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207011644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0190962207011644"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.07.016","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-12, interleukin-23, and psoriasis: Current\u00a0prospects","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}